CompletedPhase 1NCT01735318

Bioequivalence Study of Lisinopril Tablets 40 mg Under Fasting Condition

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
IPCA Laboratories Ltd.
Principal Investigator
Dr. Suhas Khandave, M.D., MD
Accutest Research Lab (I) Pvt. Ltd.
Intervention
Lisinopril Tablets 40 mg(drug)
Enrollment
40 enrolled
Eligibility
18-45 years · All sexes
Timeline
20122012

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01735318 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials